1-3 of 3
Alexey Samtsov, MD
Close
Sort by
Journal Articles

Responses to Romidepsin in Patients with Cutaneous T-Cell Lymphoma (CTCL) and Prior Treatment with Systemic Chemotherapy: Subanalysis from the Pivotal Phase 2 Study

Madeleine Duvic, MD, Youn H Kim, MD, Alain H Rook, MD, Adam Lerner, MD, Tadeusz Robak, MD, Alexey Samtsov, MD PhD, William McCulloch, M.B., FRCO, FFPM, Joel Waksman, PhD, Sean Whittaker
Journal: Blood
Blood (2014) 124 (21): 4451.
https://doi.org/10.1182/blood.V124.21.4451.4451
Published: 2014
Journal Articles

Clinically Significant Responses Achieved with Romidepsin in 37 Patient with Cutaneous T-Cell Lymphoma (CTCL) with Blood Involvement.

Youn H Kim, MD, Marie-France Demierre, MD, Ellen J Kim, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Tadeusz Robak, MD, PhD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Sean Whittaker, MD, FRCP
Journal: Blood
Blood (2009) 114 (22): 2683.
https://doi.org/10.1182/blood.V114.22.2683.2683
Published: 2009
Journal Articles

Clinically Significant Responses Achieved with Romidepsin in Treatment-Refractory Cutaneous T-Cell Lymphoma: Final Results from a Phase 2B, International, Multicenter, Registration Study

Youn Kim, MD, Sean Whittaker, MD, FRCP, Marie France Demierre, MD, Alain H Rook, MD, Adam Lerner, MD, Madeleine Duvic, MD, Sunil Reddy, MD, Ellen J Kim, MD, Tadeusz Robak, MD, Jürgen C Becker, MD, Alexey Samtsov, MD, William McCulloch, MB, FRCP, Archibald G Prentice, MBChB, FRCP, FRCPath
Journal: Blood
Blood (2008) 112 (11): 263.
https://doi.org/10.1182/blood.V112.11.263.263
Published: 2008